Cargando…

Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD

Nonalcoholic fatty liver disease (NAFLD, including nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH)) is a high-prevalence disorder, affecting about 1 billion people, which can evolve to more severe conditions like cirrhosis or hepatocellular carcinoma. NAFLD is often concomita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vitulo, Manuela, Gnodi, Elisa, Rosini, Giulia, Meneveri, Raffaella, Giovannoni, Roberto, Barisani, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454602/ https://www.ncbi.nlm.nih.gov/pubmed/37628929 http://dx.doi.org/10.3390/ijms241612748

Ejemplares similares

Interactions between Nanoparticles and Intestine
por: Vitulo, Manuela, et al.
Publicado: (2022)

Celiac disease: From genetics to epigenetics
por: Gnodi, Elisa, et al.
Publicado: (2022)

Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa
por: Gnodi, Elisa, et al.
Publicado: (2021)

The Combination of Gold and Silver Food Nanoparticles with Gluten Peptides Alters the Autophagic Pathway in Intestinal Crypt-like Cells
por: Mancuso, Clara, et al.
Publicado: (2023)

Dietary Nanoparticles Interact with Gluten Peptides and Alter the Intestinal Homeostasis Increasing the Risk of Celiac Disease
por: Mancuso, Clara, et al.
Publicado: (2021)

The Nuclear Envelope in Lipid Metabolism and Pathogenesis of NAFLD
por: Östlund, Cecilia, et al.
Publicado: (2020)

NAFLD: From Mechanisms to Therapeutic Approaches
por: Gariani, Karim, et al.
Publicado: (2022)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

Effect of Aerobic Exercise on Lipid Metabolism in Rats With NAFLD
por: Zhou, Tongxi, et al.
Publicado: (2022)

Programmed cell death and lipid metabolism of macrophages in NAFLD
por: Xiao, Zhun, et al.
Publicado: (2023)

Corrigendum: Programmed cell death and lipid metabolism of macrophages in NAFLD
por: Xiao, Zhun, et al.
Publicado: (2023)

Food additives can act as triggering factors in celiac disease: Current knowledge based on a critical review of the literature
por: Mancuso, Clara, et al.
Publicado: (2019)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

NAFLD and AATD Are Two Diseases with Unbalanced Lipid Metabolism: Similarities and Differences
por: Perez-Luz, Sara, et al.
Publicado: (2023)

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
por: Ogresta, Doris, et al.
Publicado: (2022)

The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
por: Binatti, Eleonora, et al.
Publicado: (2022)

Comprehensive Analysis of NAFLD and the Therapeutic Target Identified
por: Wen, Weiheng, et al.
Publicado: (2021)

Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD
por: Šmíd, Václav, et al.
Publicado: (2022)

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD
por: Dibba, Pratima, et al.
Publicado: (2018)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

Potential Therapeutic Targets and Promising Agents for Combating NAFLD
por: Umemura, Atsushi, et al.
Publicado: (2022)

Screening for NAFLD—Current Knowledge and Challenges
por: Forlano, Roberta, et al.
Publicado: (2023)

Lipid Disorders in NAFLD and Chronic Kidney Disease
por: Yang, Meng, et al.
Publicado: (2021)

Study of serum visfatin and blood glucose and lipid metabolism, nafld in simple obese children
por: Li, Rui-zhen, et al.
Publicado: (2015)

Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats
por: Hou, Yunhe, et al.
Publicado: (2020)

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
por: Zhang, Ziqi, et al.
Publicado: (2023)

Comorbidities and Metabolic Derangement of NAFLD
por: Bang, Ki Bae, et al.
Publicado: (2015)

Metabolic Changes of Hepatocytes in NAFLD
por: Lu, Qianrang, et al.
Publicado: (2021)

Preventative and Therapeutic Effects of Astaxanthin on NAFLD
por: Sayuti, Nor Hafiza, et al.
Publicado: (2023)

One Size Does Not Fit All: Heterogeneity in Developmental Hematopoiesis
por: Barone, Cristiana, et al.
Publicado: (2022)

p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors
por: Grassilli, Emanuela, et al.
Publicado: (2021)

Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice
por: Lei, Shan-Shan, et al.
Publicado: (2021)

Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD
por: Mashek, Douglas G.
Publicado: (2020)

The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD
por: Dixon, Emmanuel D., et al.
Publicado: (2021)

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
por: Rosato, Valerio, et al.
Publicado: (2019)

Next-Generation Sequencing Analysis of MiRNA Expression in Control and FSHD Myogenesis
por: Colangelo, Veronica, et al.
Publicado: (2014)

Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
por: Du, Xiaomi, et al.
Publicado: (2021)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Judicious Use of Lipid Lowering Agents in the Management of NAFLD
por: Iqbal, Umair, et al.
Publicado: (2018)

Scramblases as Regulators of Autophagy and Lipid Homeostasis: Implications for NAFLD
por: Chen, Allen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8icqv6ut8s57jkve6qaf4qkke9